Oculis Holding AG Ordinary shares
Symbol: OCS (NASDAQ)
17.66
▲ (0.89%) 0.155
Company Description:
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.
Key Stats
- Today's Open: $17.5
- Today's High: $17.655
- Today's Low: $17.376
- Today's Volume: 28.43K
- Yesterday Close: $17.5
- Yesterday High: $17.6
- Yesterday Low: $17.03
- Yesterday Volume: 36.48K
- Last Min Volume: 1
- Last Min High: $17.655
- Last Min Low: $17.655
- Last Min VWAP: $17.655
Company Profile
- Name: Oculis Holding AG Ordinary shares
- Website: https://www.oculis.com
- Listed Date: 2023-03-03
- Location: ,
- Market Status: Active
- CIK Number: 0001953530
- SIC Code:
- SIC description:
- Market Cap: $922.68M
- Round Lot: 100
- Outstanding Shares: 52.34M
- Asset Type: CS
RECENT FILINGS FOR OCS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-23 | 144 | View |
| 2025-08-21 | 6-K | View |
| 2025-08-01 | 6-K | View |
| 2025-06-05 | S-8 | View |
| 2025-06-05 | 6-K | View |
| 2025-05-09 | 6-K | View |
| 2025-05-08 | 6-K | View |
| 2025-04-15 | 6-K | View |
| 2025-03-14 | 144 | View |
| 2025-03-11 | 20-F | View |
| 2025-03-11 | 6-K | View |
| 2025-02-14 | 6-K | View |
| 2025-02-14 | 424B5 | View |
| 2025-02-12 | SCHEDULE 13G/A | View |
| 2025-02-11 | SCHEDULE 13G/A | View |
| 2025-01-06 | 6-K | View |
| 2025-01-03 | SCHEDULE 13G/A | View |
| 2024-12-09 | SC 13G | View |
| 2024-11-29 | 6-K | View |
| 2024-11-07 | SC 13G/A | View |
Latest News on OCS